Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

0.6800 +0.0100 (+1.49%)
Streaming Delayed Price Updated: 11:08 AM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biotricity Inc

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 13.2% to $12.0 during Thursday's regular session. The market value of their outstanding shares is at $417.9 million.... 
Via Benzinga
Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show
Benzinga is thrilled to announce the guest lineup for our next All Access show, set to air Thursday, October 7 at 9:00 am ET. Thursday's Guest Lineup The theme... 
Via Benzinga
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
Biotricity (NASDAQ: BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring,... 
Via Benzinga
Biotricity Reports Q1 Earnings at 290% for FY2022
Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always... 
Via Benzinga
Biotricity Uplists to Nasdaq, Poses Significant Buying Opportunity for Investors
Image via Biotricity.com Thursday, August 26, 2021, Biotricity, Inc. (NASDAQ: BTCY) uplisted to Nasdaq after raising $15 million to fuel its continued growth and expansion.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN 
Via Benzinga
Biotricity Completes Nasdaq Listing
Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ: BTCY), a medical diagnostic and consumer... 
Via Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and... 
Via Talk Markets
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (... 
Via Benzinga
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced... 
Via Benzinga
Who is Dr. Waqaas Al-Siddiq, and Why are His Wearables the Most Crucial Devices MedTech Has Ever Seen?
Biotricity Inc. (NASDAQ: BTCY) is a medtech startup that has seen quarter-over-quarter (QoQ) growth since its inception within the cardiac arena, and just listed on the NASDAQ as... 
Via Benzinga
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures COVID-19
Innovative Company Biotricity is Providing Solutions for Chronic Diseases
A new study revealed that 44% of older millennials that will soon hit 40 suffer at least one chronic health condition that takes a toll, both financially and emotionally —... 
Via Benzinga
Healthy Hearts and Healthy Wallets: Why one Healthtech Startup is a Must-Invest
Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!... 
Via Benzinga
Why A Northstar Analyst Is Bullish On This Disruptive MedTech Company
A strong value proposition and high retention rate have turned Northland Capital Markets bullish on Biotricity, Inc (OTC: 
Via Benzinga
Lasting Impact of Covid: Fewer Doctor's Office Visits Thanks to At-Home Diagnostics
While treatment has long been viewed as the central role of our healthcare system, the COVID-19 pandemic brought diagnostics to center stage. Early and accurate detection was... 
Via Benzinga
Exposures COVID-19
Maxim Group Is Bullish About Biotricity Generating Over 100% Revenue Growth
Biotricity Inc (OTC: BTCY) has a multi-billion dollar target addressable market, which should expand as an ecosystem is created for solutions to chronic conditions, according to... 
Via Benzinga
Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology
The following article is sponsored by Biotricity Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.